As a pediatric oncologist, I specialize in treating pediatric leukemia and lymphoma, emphasizing the use of cellular therapy. Cellular therapy involves modifying a patient’s own cells or cells from a donor to fight disease.
I have long been inspired by the strength and bravery of children going through cancer diagnosis and treatment. It is an incredibly difficult process. I'm passionate about providing longitudinal care while guiding patients and their families through this challenging time. I strive to treat every patient I meet with the utmost respect, care, patience, honesty and dedication.
My research focuses on using new and emerging cellular therapy techniques to better treat difficult-to-manage leukemias and lymphomas and the management of important side effects such as viral infections. I am the recipient of a St. Baldrick's Fellow research grant from July 2020 to July 2022, looking at the use of T-cell therapy to prevent viral infections.
I love to spend my free time with my wife, son and daughter. I also like to run, read books and play basketball.
Pediatric oncology; leukemia; lymphoma; cellular therapy; post-transplant lymphoproliferative disorder (PTLD)
Viral infections are a significant source of morbidity and mortality in patients following hematopoietic stem cell transplant and antiviral medications carry high toxicity profiles often with suboptimal response. Dr. Rubinstein's research focuses on the use of virus-specific T cell (VST) therapy to combat a number of viruses seen after both stem cell transplantation and solid organ transplantation. He is involved in numerous clinical trials seeking to optimize the use of this approach and works closely with laboratory-based collaborators to improve knowledge and understanding of their mechanism of action.
Assistant Professor, UC Department of Pediatrics
Cancer and Blood Diseases